Kai Chen

2.6k total citations
87 papers, 1.4k citations indexed

About

Kai Chen is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Kai Chen has authored 87 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Cancer Research, 40 papers in Oncology and 31 papers in Pathology and Forensic Medicine. Recurrent topics in Kai Chen's work include Breast Cancer Treatment Studies (44 papers), Breast Lesions and Carcinomas (28 papers) and HER2/EGFR in Cancer Research (15 papers). Kai Chen is often cited by papers focused on Breast Cancer Treatment Studies (44 papers), Breast Lesions and Carcinomas (28 papers) and HER2/EGFR in Cancer Research (15 papers). Kai Chen collaborates with scholars based in China, United States and Hong Kong. Kai Chen's co-authors include Fengxi Su, Liling Zhu, Erwei Song, Shunrong Li, Lisa K. Jacobs, Weijuan Jia, Jieqiong Liu, Qiang Liu, Fengxi Su and Nanyan Rao and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Kai Chen

81 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai Chen China 22 718 560 493 427 227 87 1.4k
Giuseppe Canavese Italy 26 1.0k 1.4× 787 1.4× 650 1.3× 612 1.4× 134 0.6× 76 1.8k
H. Curé France 22 742 1.0× 410 0.7× 1.2k 2.5× 367 0.9× 106 0.5× 82 2.0k
Patricia Tai Canada 20 466 0.6× 297 0.5× 664 1.3× 340 0.8× 78 0.3× 80 1.5k
Byung Joo Chae South Korea 18 409 0.6× 283 0.5× 372 0.8× 372 0.9× 76 0.3× 104 1.2k
F. Campana France 22 1.2k 1.7× 732 1.3× 840 1.7× 350 0.8× 321 1.4× 68 2.0k
Naveen Faridi Pakistan 24 345 0.5× 311 0.6× 570 1.2× 291 0.7× 79 0.3× 85 1.4k
Lisa M. Sclafani United States 18 1.2k 1.6× 808 1.4× 585 1.2× 982 2.3× 81 0.4× 38 1.8k
Byung Joo Song South Korea 27 593 0.8× 550 1.0× 449 0.9× 484 1.1× 96 0.4× 112 2.2k
Sung Whan Ha South Korea 29 649 0.9× 355 0.6× 892 1.8× 636 1.5× 102 0.4× 126 2.1k
Daniel Vorobiof South Africa 18 300 0.4× 340 0.6× 938 1.9× 156 0.4× 98 0.4× 61 1.6k

Countries citing papers authored by Kai Chen

Since Specialization
Citations

This map shows the geographic impact of Kai Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Chen more than expected).

Fields of papers citing papers by Kai Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Chen. The network helps show where Kai Chen may publish in the future.

Co-authorship network of co-authors of Kai Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Chen. A scholar is included among the top collaborators of Kai Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Chen. Kai Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Kai, Diansheng Chen, Ruijie Zhang, Meng Cai, & Zhouping Tang. (2025). MonoTracker: Monocular-Based Fully Automatic Registration and Real-Time Tracking Method for Neurosurgical Robots. Chinese Journal of Mechanical Engineering. 38(1).
2.
Chen, Kai, Ping Wei, & Jinghua Chen. (2025). Antioxidant Glycopolypeptide Micelles for Targeted Delivery of Silibinin to Hepatocellular Carcinoma Cells. Chinese Journal of Polymer Science. 43(11). 2051–2060.
3.
Chen, Mingkun, Kai Chen, Kunxin Luo, et al.. (2025). GhWRKY41 Confers Salt Tolerance by Enhancing Photosynthetic Capacity in Cotton ( Gossypium hirsutum ). Plant Cell & Environment. 49(1). 554–571. 1 indexed citations
4.
Yang, Junjie, Xingxing Gu, Jun Li, et al.. (2024). Metal–organic framework-derived materials for enhanced performance of aqueous zinc ion batteries: a mini review. CrystEngComm. 26(38). 5314–5323. 4 indexed citations
6.
Chen, Kai, et al.. (2024). CECL-Net: Contrastive Learning and Edge-Reconstruction-Driven Complementary Learning Network for Image Forgery Localization. Electronics. 13(19). 3919–3919. 2 indexed citations
9.
Jin, Liang, Kai Chen, Cui Tan, et al.. (2020). Prognostic Value of Modified IHC4 Score in Patients with Estrogen Receptor-Positive Metastatic Breast Cancer. The Oncologist. 25(8). e1170–e1180. 6 indexed citations
10.
Chao, Xue, Xiaoyan Jin, Cui Tan, et al.. (2020). Re-excision or “wait and watch”—a prediction model in breast phyllodes tumors after surgery. Annals of Translational Medicine. 8(6). 371–371. 16 indexed citations
11.
Lin, Yanzhu, et al.. (2019). Long-Term Outcomes of Three-Dimensional High-Dose-Rate Brachytherapy for Locally Recurrent Early T-Stage Nasopharyngeal Carcinoma. Frontiers in Oncology. 9. 278–278. 3 indexed citations
12.
Lu, Yiwen, Yanbo Chen, Liling Zhu, et al.. (2019). Local Recurrence of Benign, Borderline, and Malignant Phyllodes Tumors of the Breast: A Systematic Review and Meta-analysis. Annals of Surgical Oncology. 26(5). 1263–1275. 119 indexed citations
13.
Wang, Yan, Kai Chen, Yaping Yang, et al.. (2019). Incidence and survival outcomes of early male breast cancer: a population-based comparison with early female breast cancer. Annals of Translational Medicine. 7(20). 536–536. 14 indexed citations
14.
Chen, Kai, Liling Zhu, Lili Chen, et al.. (2019). Circumferential Shaving of the Cavity in Breast-Conserving Surgery: A Randomized Controlled Trial. Annals of Surgical Oncology. 26(13). 4256–4263. 13 indexed citations
15.
Pan, Zihao, Liling Zhu, Jianguo Lai, et al.. (2018). Predicting initial margin status in breast cancer patients during breast-conserving surgery. OncoTargets and Therapy. Volume 11. 2627–2635. 7 indexed citations
16.
Li, Mingzhu, Kai Chen, Fengtao Liu, et al.. (2017). Nipple sparing mastectomy in breast cancer patients and long-term survival outcomes: An analysis of the SEER database. PLoS ONE. 12(8). e0183448–e0183448. 25 indexed citations
17.
Chen, Kai, Shunrong Li, Qian Li, et al.. (2016). Breast-conserving Surgery Rates in Breast Cancer Patients With Different Molecular Subtypes. Medicine. 95(8). e2593–e2593. 19 indexed citations
18.
Jia, Weijuan, et al.. (2014). HER2-enriched Tumors Have the Highest Risk of Local Recurrence in Chinese Patients Treated with Breast Conservation Therapy. Asian Pacific Journal of Cancer Prevention. 15(1). 315–320. 16 indexed citations
19.
Jia, Haixia, Weijuan Jia, Yaping Yang, et al.. (2014). HER-2 positive breast cancer is associated with an increased risk of positive cavity margins after initial lumpectomy. World Journal of Surgical Oncology. 12(1). 289–289. 20 indexed citations
20.
Zhao, Jianli, Jieqiong Liu, Kai Chen, et al.. (2014). What lies behind chemotherapy-induced amenorrhea for breast cancer patients: a meta-analysis. Breast Cancer Research and Treatment. 145(1). 113–128. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026